DIAGNOSIS OF WILSON’S DISEASE – A 20-YEAR AUDIT Geetha Rathnayake 1, Mirette Saad 2, Kay Weng Choy 1, James CG Doery 1,3 1 Monash Pathology, Monash Medical.

Slides:



Advertisements
Similar presentations
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Advertisements

Severe combined immune deficiency in Nablus Omar Abuzaitoun, MD.
REYE’S SYNDROME BY: JENNIFER DELANEY. OBJECTIVES HISTORY HISTORY ETIOLOGY ETIOLOGY WHAT IT DOES WHAT IT DOES SIGN & SYMPTOMS SIGN & SYMPTOMS STAGES STAGES.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
HEMOCHROMATOSIS Wendy Graham, MD, CCFP Academic ½ Day November 25, 2003.
Hepatic Adenoma 2005.Incidence of HCC in adenomas-8 to 14% “The surgeon is tempted to operate. However in most uncomplicated cases of adenoma it.
CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FIVE Dr. Essam H. Aljiffri.
Genetic Testing for Wilson Disease Melissa Dempsey, M.S., CGC The University of Chicago Genetic Services Laboratory July 17, 2010.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Wilson’s Disease The Genetic Disorder You’ve Probably Never Heard Of.
Approach to medical liver biopsies Dr Behrang Mozayani Consultant Histopathologist Southmead hospital Bristol.
Cervical screening Tim Wright Sept 07. Introduction What who when What who when Benefits (evidence) Benefits (evidence) Cost Cost Does it fit wilson’s.
Acute Hepatitis in a 19 Year Old Weightlifter on Dietary Supplements Ann Sheehy Reed, M.D., M.S. May 30, 2007.
By: Lauren Filice Jasmine Mateo Monica La Borde Wilson Disease.
Wilson Disease By Geo Cherian Roll no OUTLINE What is Wilsons Disease Genetics Normal Copper Physiology/metabolism Pathogenesis Morphology Manifestation.

Wilson's Disease hepatolenticular degeneration Copper storage disease Wilson's disease causes the body to take in and keep too much copper. The copper.
Dr. Paramita Sengupta Department Of Community Medicine Christian Medical College Ludhiana Co-authors: Ragini Mann, Rohit Theodore, A I Benjamin Risk factors.
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
Eleni Galani Medical Oncologist
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
The Nature of Disease.
Wilson Disease Treatment Failures?
BY ALI LORD AND GARD HERLOFSEN
Neurological Manifestations of Wilson’s Disease Aleksandar Videnovic, MD, MSc Assistant Professor of Neurology Feinberg School of Medicine Northwestern.
Primary Sclerosing Cholangitis
Wilson’s Disease, A Disease to know Abdulwahab Telmesani FRCPC,FAAP Faculty of Medicine and Medical Science Umm Al-Qura University.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
ATAXIA TALANGIECTASIA
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Other causes of Cirrhosis: Genetic eg. Wilson's Disease, Hemochromatosis Autoimmune eg. Autoimmune Hepatitis, Primary Biliary Cirrhosis, Primary Sclerosing.
Specific Aim 1: Determine the impact of psychiatric disorders on the hospital length of stay (LOS) in pediatric patients diagnosed with SCD admitted for.
Introduction to Pathophysiology. Definitions Pathophysiology-the physiology of abnormal states; specifically the functional changes that accompany a particular.
Dr K N Prasad Community Medicine
LOW RELIABILITY OF HOME-BASED DIAGNOSIS OF MALARIA IN A RURAL COMMUNITY IN WESTERN KENYA Rose Kakai (1), Josephine Nasimiyu (2), 1 Wilson Odero (1) 1 Maseno.
Wilson’s Disease Ho Yin Calvin Chu, Sanghyuk (Simon) Oh, Soojin Oh, Zi Teng (Steven) Shao PHM142 Fall 2015 Instructor: Dr. Jeffrey Henderson.
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Hepatocellular Carcinoma from the ACC to Med E Paul M. Johnson Department of Internal Medicine University of North Carolina Hospitals February 12, 2010.
بسم الله الرحمن الرحيم. Adult Hodgkin’s Lymphoma in the Eastern Part of Libya Dr. M.Mangoush, R. Nafo, S.Kardah, M.Letaiwish, S.Kardah, F.Bodabous, S.Ebkhatra.
© Cancer Research UK 2002 Registered charity number Figure One: Numbers of new cases and rates by age and sex, brain and other central nervous.
Chapter 37 Chronic Kidney Disease: The New Epidemic
Sunil Kumar, B.K.Kapoor, Urvinderpal Singh, Vidhu Mittal Department of Pulmonary Medicine, GMC,Patiala PRESENTATION OF PULMONARY TUBERCULOSIS IN ELDERLY.
Heptolenticular Degeneration By Toni Ajoje
Dr Michelle Webb Renal Consultant, Associate Medical Director Patient Safety, East Kent Hospitals University NHS Foundation Trust and Co-lead for Sepsis.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
The Royal College of Emergency Medicine VTE Risk in Lower Limb Immobilisation in Plaster Cast Clinical Audit National findings The Royal College.
BY: MARIA BEECHER Wilson’s Disease. Intro Samuel Alexander Kinnier Wilson 1 in 30,000 people Rare genetic disease  Build up of copper Affected organs.
HEPATOLOGY, Vol. 61, No. 6, Introduction At least 1 / 3 of liver cirrhosis (LC) Chronic hepatitis B (CHB) Significant proportion of CHB progress.
Kris V. Kowdley, Patricia Belt, Laura A. Wilson, Matthew M. Yeh, Brent A. Neuschwander-Tetri, Naga Chalasani, Arun J. Sanyal, and James E. Nelson ; for.
Dr. Iram Shad PGT-Medicine MU-1, HFH,RWP
What Causes Wilson Disease? Wilson disease is caused by mutations in the ATP7B gene. This gene makes an enzyme that is involved in copper transport.
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
MonashPathology MonashHealth
September 12th, 2011 Good Morning.
Dr. M. SOFI MD; FRCP (London); FRCPEdin; FRCSEdIn
Nilika G Wijeratne1, James CG Doery1,2
Asmaa Hmaid Esraa Shbair
MonashPathology 17-HYDROXYPROGESTERONE ASSAYS – TIME FOR HARMONISATION
Metabolic Disorders Hemochromatosis
Figure 3. The majority of patients have obstructive lung function
Primary biliary cirrhosis, cirrhotic stage
Chapter 3 Fatty Liver Diseases 1 Alcoholic steatosis Case 3.1.
HEPATOLENTICULAR DEGENERATION
Primary Biliary Cholangitis
Wilson’s Disease Dr.mousavi Abadan –Khordad-1397.
Recognising sepsis and taking action
EASL Clinical Practice Guidelines: Wilson’s disease
No matter what the type of genetic screening, certain core principles should be followed before a program is introduced. Principles of Screening • The.
Presentation transcript:

DIAGNOSIS OF WILSON’S DISEASE – A 20-YEAR AUDIT Geetha Rathnayake 1, Mirette Saad 2, Kay Weng Choy 1, James CG Doery 1,3 1 Monash Pathology, Monash Medical Centre; 2 Australian Clinical Labs; 3 Department of Medicine, Monash University, Clayton Vic Only five patients had presence or absence of KF rings documented KF rings may be absent in children Seven patients first presented with neurologic or psychiatric findings including learning difficulties, psychosis, limb inco-ordination and tremor. WD may not be considered a differential diagnosis for such subtle and non-specific features Almost half (44%) first presented with liver disease both early and advanced. First presentation with liver diseases can occur at any age All patients fulfilled the International Wilson’s Disease Leipzig scoring system for diagnosis which is available on-line. y/for-physicians/wilsons-disease-scoring- system/ y/for-physicians/wilsons-disease-scoring- system/ Early diagnosis has positive impact on prognosis but is very challenging as early symptoms are non-specific. Wilson’s should be suspected in any patient with unexplained liver disease, neurological or neuropsychiatric disorder. East Asian populations have at least double the incidence of other ethnicities. MonashPathology MonashHealth METHODS Hospital medical records and pathology database of all patients diagnosed with WD at Monash Health over last 20 years were examined. (n=18) The initial clinical presentation as well as serum copper, serum caeruloplasmin, 24-hour urinary copper, liver tests, and liver copper were reviewed CONCLUSION Wilson’s disease is an uncommon disease which is very challenging to diagnose at an ideally early stage because neurologic symptoms and liver test abnormalities are far more commonly caused by other conditions. No one particular presenting symptoms or signs were specific to particular age groups i.e. any feature could present at any age This audit confirms that the Leipzig scoring system provides best diagnostic accuracy Chemical Pathologists and other clinicians must appreciate the limitation of individual tests for WD and communicate effectively to ensure accurate diagnosis. Liver biopsy; brown rhodanine stain specific for copper deposition INTRODUCTION Wilson disease (WD) was first described in 1912 by Kinnear Wilson as “progressive lenticular degeneration,” a familial, lethal neurological disease accompanied by chronic liver disease leading to cirrhosis and hepatic malignancy. It is a rare autosomal recessive disorder of the ATP7B gene controlling biliary copper excretion, leading to copper accumulation in many organs. (Figure 1) (1) Most common presentations are with liver disease, neurologic or psychiatric symptoms It is fatal if not recognised and treated when symptomatic. Diagnosis is based on a combination of clinical findings and laboratory tests to create a Leipzig diagnostic risk score. (2) No blood test has 100% sensitivity for Wilson’s disease. Leipzig scoring system provides best diagnostic accuracy REFERENCES 1.Roberts E A, Schilsky M L. Diagnosis and Treatment of Wilson Disease: An Update. AASLD Practice Guidelines. HEPATOLOGY, Vol. 47, No. 6, 2008: European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Wilson’s Disease. J Hepatology (2012) 56: Fig 1. Clinical presentations of Wilson’s disease AIM To examine the clinical presentation and relative values of laboratory tests in the diagnosis of Wilson’s disease Initial presenting features ProportionAge Presentation Kayser- Fleischer (KF) rings 3 of 5 tested Neurologic or psychiatric symptoms 40% Liver disease / liver failure 44% Abnormal laboratory presentation Low serum copper 72% Low serum caeruloplasmi n 72% High urine copper 61% Liver copper elevated 6 of 6 tested Initial presenting features of our Wilson’s disease patients RESULTS & DISCUSSION Leipzig International Wilson’s Disease scoring system Age of presentation varied from 10 to 54 years (67% years); 78% males, 22% females; 55% of Asian origin, based on family name WD may present symptomatically at any age The predominant Asian origin reflects the higher incidence in East Asians plus local population demographics